Pearson and Imperial punished for similar failings

Negative surprises that look like they could have been avoided link Pearson’s and Imperial’s sharp stock price falls

Negative surprises that look like they could have been avoided link Pearson’s and Imperial’s sharp stock price falls

The unusual sight of two FTSE 100 blue-chips falling by double-digit percentage amounts on the same day is coincidental. Guidance that wrong-footed both sets of investors is probably more important than their geographic link.

Pearson, the educational publisher, has troubles in the U.S. university market that go back more than half a decade. One major part is down to enrolments largely flatlining since 2010, according to Bloomberg data. Another is due to ‘substitution’: more and more educational materials are available for free. The ferocity of Thursday’s selling—the stock cratered by 19% at one point—also suggests resumed investor annoyance for the return of what looks like clumsy expectations management, at best. Pearson’s warning points to adjusted 2019 operating profit coming in at the lower end of a £590m-to-£640m guidance range. Yet it follows commentary in recent months giving the strong impression of recovery of Pearson’s U.S. courseware business.

Imperial Brands has faced similar criticism, though disquiet about how the tobacco company handled its own warning has been more vocal. U.S. regulators have been busy in recent weeks paving the way for likely sweeping new restrictions on vaping. The latest development was an FDA warning about a serious though unexplained lung illness among vapers. Consequently, shares of U.S. smoking product makers have decoupled from Wall Street’s rising trend this year. Altria, for instance, is down 18% in 2019. Imperial’s stock shows a similar flavour; now underperforming the FTSE 100 with a 21% fall against the benchmark’s 9% rise this year. Yet the maker of Gauloises, Rizla, Golden Virginia and Blu vaping devices was accused on Thursday, by an analyst at brokerage RBC, of ‘not making sense’. IMB stock dumped 12% at its worst after the group said earnings were unlikely to grow in its current financial year—which ends on 30th September. Previously, income was forecast between 4% and 8%. Sales will now grow by 2%, against a previously given range of 1%-4%. Somehow, Imperial still expects its unprofitable smoking-alternative business to break even in 2020.

All told, takeaways from IMB/PSON troubles relate more to their specific industries than consumer markets overall. Imperial may be the latest smoking product firm to lose a grip on risks in the highly-regulated business, though is unlikely to be the last. Pearson’s challenges are more structural. A significant cycle of cost cuts has not righted a long-standing fault line in the segment from which it generates 25% of revenue. Both groups’ shares are set to remain under pressure into the year end.

Thoughts on Pearson Plc. chart

The consequences of PSON’s destroyed two-year rising trend line (confirmed by failure from below in late-July) continue to reverberate. Also note a decline connected by highs all the way back to April 2015. Together both lines created a giant wedge of reckoning. The stock duly broke to the downside of this in February and has been beneath it ever since. The farther tip of the falling trend now adds resistance. The shares have also crashed through supportive lows around 763p to 790p that began appearing last October. They should now pose resistance too. Eyes are now drawn to potential support at the definitively defended 651p and 565p lows from last February and September 2017.

Pearson CFD – Weekly [26/09/2019 14:19:58]

Source: City Index


Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.